What is your approach to treating relapsed subcutaneous panniculitis-like T-cell lymphoma?
Does it differ from the treatment of other relapsed peripheral T-cell lymphomas?
Are there any clinical trials or case series focused on SPTCL?
Is there data to guide the choice between consolidative autologous vs allogeneic HCT for SPTCL in CR2?
1 Answer
Mednet MemberInvited Expert
Medical Oncology · UT MD Anderson Cancer Center
Answered on
Over the years the SPTL has been characterized better and the latest WHO lists it under PTCL with an α/β T-cell phenotype (SPTL-AB) and this has to be distinguished from primary cutaneous TCL with a γδ T-cell phenotype (PTCL-GD). Since they are so rare a workshop of the multidisciplinary EORTC Cutan...
Join for free or sign in to see the full answer